Skip to main content

Table 1 Demographics and diabetes history of study population

From: Hypoglycemia incidence and awareness among insulin-treated patients with diabetes: the HAT study in Brazil

  T1DM (n = 321) T2DM (n = 293)
Female sex, n (%) 188 (58.8%) 162 (55.5%)
Age (years), median [Q1, Q3] 33.0 [26.0, 44.0] 62.0 [55.0, 68.5]
Full-time employment, n (%) 136 (45.5%) 58 (21.2%)
Duration of diabetes (years), median [Q1, Q3] 15.0 [9.0, 22.0] 15.0 [10.0, 22.0]
Last measured HbA1c value (%), median [Q1, Q3] 7.7 [7.0, 8.5] 7.9 [7.3, 9.1]
Checks blood sugar levels, n (%) 314 (98.4%) 259 (88.7%)
Has ever experienced hypoglycemia, n (%) 313 (97.5%) 247 (84.3%)
(if yes) Patients identifying hypoglycemia based on, n (%)
 Symptoms only 83 (27.4%) 96 (41.4%)
 Blood glucose measurement only 23 (7.6%) 38 (16.4%)
 Either symptoms or a blood glucose measurement 56 (18.5%) 28 (12.1%)
 Both symptoms and blood glucose measurement 129 (42.6%) 65 (28.0%)
 Other 12 (4.0%) 5 (2.2%)
 Missing 18 61
Duration of insulin use (years), median [Q1, Q3] 14.0 [8.0, 22.0] 6.0 [3.0, 10.0]
Diabetes treatment, n (%)a
 Only short-acting insulin 26 (8.2%) 15 (5.1%)
 Only long-acting insulin 14 (4.4%) 123 (42.0%)
 Both short- and long-acting insulin 250 (77.9%) 137 (46.8%)
 Mixed insulin 12 (3.8%) 11 (3.8%)
 Insulin pump 17 (5.3%) 1 (0.3%)
 Oral anti-diabetes treatment 29 (9.1%) 177 (60.4%)
 Injectable anti-diabetes treatments other than insulin 44 (13.8%) 4 (1.4%)
Patients who completed second questionnaire 276 (86.0%) 254 (86.7%)
  1. Q1 lower quartile, Q3 upper quartile
  2. aEach patient can use more than one treatment for diabetes